| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.005 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |